Publication | Closed Access

Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line

OncologySignaling PathwayMedicinePten ReductionTumor SuppressorRadiation OncologyCancer BiologyCell BiologyTumor BiologyPi3k/akt PathwayOvarian Cancer